Author | Udit Verma, MD | OncLive

Author | Udit Verma, MD

Articles

Dr. Udit Verma on Regorafenib in Patients With mCRC

April 13, 2016

Video

Udit Verma, MD, associate professor of Internal Medicine in Hematology/Oncology, UT Southwestern Medical Center, discusses a subgroup analysis of the CONSIGN study, which examined regorafenib (Stivarga) in patients with metastatic colorectal cancer.

x